Actavis Recalls Diclofenac/Misoprostol Tablets Due to Broken Tablets
Actavis recalls specific lots of Diclofenac Sodium and Misoprostol Delayed-Release Tablets because they may be broken, affecting product specifications.
Recall notice
Failed Tablet/Capsule Specifications: Broken tablets
Contact the company
What happened, in plain English
Actavis Inc is recalling specific lots of Diclofenac Sodium and Misoprostol Delayed-Release Tablets (75mg/0.2mg) manufactured by Watson Laboratories, Inc. The recall is necessary because the tablets failed specification tests due to being broken. This issue affects 6,540 bottles distributed nationwide. Read more at govinfonow.com/recall/48214-actavis-inc-recalls-diclofenac-sodium-and-misoprostol-delayed-release-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/48214-actavis-inc-recalls-diclofenac-sodium-and-misoprostol-delayed-release-tablets · Updated October 13, 2026 · FDA enforcement record: FDA #D-1060-2014
Cite this page
“Actavis Recalls Diclofenac/Misoprostol Tablets Due to Broken Tablets.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48214-actavis-inc-recalls-diclofenac-sodium-and-misoprostol-delayed-release-tablets. Based on FDA recall #D-1060-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1060-2014%22&limit=1).
Why it’s dangerous
The tablets failed to meet quality specifications because they were broken. Broken tablets may not deliver the correct dosage or may have altered release properties, potentially affecting the medication's efficacy or safety profile, though the record does not specify specific injuries resulting from this defect.
Who’s affected
Consumers who purchased the recalled prescription medication from pharmacies or distributors across the United States between the manufacturing date and the recall announcement on March 22, 2013. Patients relying on these specific lots for their treatment are at risk of receiving defective product.
How to tell if you have this one
Check your prescription bottle for NDC 0591-0398-60 (60 count bottles). Verify the lot number is either 668271A with an expiration date of 11/14, or 684119A with an expiration date of 01/2015. The product was manufactured by Watson Laboratories, Inc. in Corona, CA.
- Brand
Actavis- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1060-2014 (March 22, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1060-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.